COChan-Jin Oh

Chan-Jin Oh

*This is an algorithmically generated author record based on publicly available information.

Chan-Jin Oh has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Floristic Study of Sangwangsan Mt. and Its Adjacent Areas(Wando-gun)1

    by Wando-Gun 59105 Jeollanam-Do Wando Arboretum, Gwang-Il Kim, Chan-Jin Oh, Sun-Jin Lee, Soon-Ho Shin, Kyoung-Pae Yun


  • Open Access

    Stachyurus praecox (Stachyuraceae), first report in Korea

    by Chan-Jin Oh, Soon-Ho Shin, Ji-Woong Cho, Hyoun-Woo Kim, Sang-Sub Han, Ji-Won Kim, Jae-Min Chung

    We report a previously unrecorded woody species, Stachyurus praecox Siebold & Zucc. (Stachyuraceae), in Korea. This species is considered to be endemic to Japan. Stachyurus praecox was collected for the first time in an evergreen forest on an uninhabited island of Bongsun-ri, Saengil-myeon, Wando-gun, Jeollanam-do in Korea. The inflorescence of the species was racemose and pendulous on the axils of the previous year’s branches. Flowers bloomed from March to April. They were functionally dioecy but morphologically hermaphrodite. This woody species was named ‘Wan-do-sul-kkot-na-mu’ in Korean based on the shape of its inflorescence. Morphological characteristics and illustrations of this woody species have been provided with a distribution map and photographs of the natural habitat.


  • Open Access

    Acteoside Counteracts Interleukin‐1β‐Induced Catabolic Processes through the Modulation of Mitogen‐Activated Protein Kinases and the NFκB Cellular Signaling Pathway

    by HyangI Lim, Do Kyung Kim, Tae-Hyeon Kim, Kyeong-Rok Kang, Jeong-Yeon Seo, Seung Sik Cho, Younghee Yun, Ye-Yong Choi, Jungtae Leem, Hyoun-Woo Kim, et al.

    Osteoarthritis (OA) is the most common degenerative joint disease with chronic joint pain caused by progressive degeneration of articular cartilage at synovial joints. Acteoside, a caffeoylphenylethanoid glycoside, has various biological activities such as antimicrobial, anti‐inflammatory, anticancer, antioxidative, cytoprotective, and neuroprotective effect. Further, oral administration of acteoside at high dosage does not cause genotoxicity. Therefore, the aim of present study is to verify the anticatabolic effects of acteoside against osteoarthritis and its anticatabolic signaling pathway. Acteoside did not decrease the viabilities of mouse fibroblast L929 cells used as normal cells and primary rat chondrocytes. Acteoside counteracted the IL‐1β‐induced proteoglycan loss in the chondrocytes and articular cartilage through suppressing the expression and activation of cartilage‐degrading enzyme such as matrix metalloproteinase‐ (MMP‐) 13, MMP‐1, and MMP‐3. Furthermore, acteoside suppressed the expression of inflammatory mediators such as inducible nitric oxide synthase, cyclooxygenase‐2, nitric oxide, and prostaglandin E2 in the primary rat chondrocytes treated with IL‐1β. Subsequently, the expression of proinflammatory cytokines was decreased by acteoside in the primary rat chondrocytes treated with IL‐1β. Moreover, acteoside suppressed not only the phosphorylation of mitogen‐activated protein kinases in primary rat chondrocytes treated with IL‐1β but also the translocation of NFκB from the cytosol to the nucleus through suppression of its phosphorylation. Oral administration of 5 and 10 mg/kg acteoside attenuated the progressive degeneration of articular cartilage in the osteoarthritic mouse model generated by destabilization of the medial meniscus. Our findings indicate that acteoside is a promising potential anticatabolic agent or supplement to attenuate or prevent progressive degeneration of articular cartilage.